• About Genmab
    • About Genmab
    • Board of Directors
    • Senior Leadership Team
    • Corporate Social Responsibility
    • Partnerships
    • FAQ
  • Science & Research
    • Products In Development
    • Licensing Opportunities
    • Clinical Trials
    • Introduction to Antibodies
    • Antibody Discovery
    • Next Generation Technology
    • Scientific Articles
  • Investor Center
    • InvestorPortal
    • Stock Quotes
    • Financial Calendar
    • Stock Information
    • Analysts
    • Events
    • Investor Contact
    • Corporate Documents
    • Warrant Scheme
  • Press Center
    • Recent News Releases
    • Archived News Releases
    • Press Contact
  • Careers
    • Career Opportunities
  • Contact Genmab
    • Contact Genmab
    • Subscribe to Genmab News

Hot News

Arzerra Fourth Quarter and Full Year 2011 Net Sales Figures...»
Genmab Announces Progress with DuoBody™ Platform...»
Genmab Announces Progress with Lundbeck Collaboration ...»
Genmab Announces Preliminary Safety and Efficacy Data for Daratumumab...»
More Genmab News Releases

Science & Research

  • Products In Development
  • Licensing Opportunities
    • Zalutumumab
    • HuMax-HepC
    • HuMax-TAC
    • DuoBody
    • UniBody
  • Clinical Trials
  • Introduction to Antibodies
  • Antibody Discovery
  • Next Generation Technology
  • Scientific Articles
  • Home
Print

Legal Notice
Use of this Site is subject to Important Legal Terms, which you are requested to read prior to proceeding.
© 2011 Genmab A/S
Science And Research » Licensing Opportunities » UniBody

UniBody

Genmab is seeking to out-license our UniBody technology.

A Non-Confidential Brochure is available.

A confidential data package is available after execution of a suitable non-disclosure agreement (CDA). Interested parties may request a one way CDA or a two way CDA.

Registered users may access the Confidential Data Room here.